The Board of directors exercises authorisation for repurchase of shares for the purpose of securing the company’s commitments under the incentive programme
The Annual General Meeting of Swedish Orphan Biovitrum AB (publ) (Sobi™) on 4 May 2021, resolved – for the purpose of ensuring that the company can fulfil its commitments under the long-term incentive programme resolved by the Annual General Meeting – on a directed share issue of no more than 3,298,984 redeemable and convertible class C shares. The meeting also resolved to authorise the Board of directors to resolve on the repurchase of all issued class C shares by an offer directed to all holders of class C shares. Repurchase under this authorisation may be made